Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Carvedilol
All strengths: Limited Use, Reason for Use code 183 required; same patient cost rules
Shared coverage and patient cost rules
StatusLimited Use, Reason for Use code 183 required
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Auro-Carvedilol · DIN 02418495 · 3.125 mg · tablet
Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit:
For patients with:
Reason for Use code 183
a) NYHA Class II or III Congestive Heart Failure (CHF); and
b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and
c) An ejection fraction less than or equal to 35%; and
d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Auro-Carvedilol · DIN 02418495
Manufacturer: Auro Pharma Inc.; listing date 2014-04-30
Daily cost (source): $0.4120
Health Canada: Marketed since 2014-02-06 · brand AURO-CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 3.125 MG · company Auro pharma inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordAuro-Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.
Ministry pays: $0.2060 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02418495)
Source record
DIN 02418495: Auro-Carvedilol
Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y
Item: 240400140; group id 278; item number 0576; lccId 00050; manufacturer id AUR
Source form: Tab; strength: 3.125mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.2060; ministry $0.2060
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02418495
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=90306
Interchangeable products
Apo-Carvedilol · DIN 02247933 · $0.2060
Carvedilol · DIN 02248752 · $0.2060
Carvedilol · DIN 02364913 · $0.2060
Coreg · DIN 02229650 · not recorded
Jamp-Carvedilol · DIN 02368897 · $0.2060
PMS-Carvedilol · DIN 02245914 · $0.2060
Ran-Carvedilol · DIN 02268027 · $0.2060
Ratio-Carvedilol · DIN 02252309 · $0.2060
Shortage status: resolved shortage (ended September 15, 2023); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02418495
Shortage record checked October 6, 2026
Carvedilol · DIN 02248752 · 3.125 mg · tablet
Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit:
For patients with:
Reason for Use code 183
a) NYHA Class II or III Congestive Heart Failure (CHF); and
b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and
c) An ejection fraction less than or equal to 35%; and
d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Carvedilol · DIN 02248752
Manufacturer: Sivem Pharmaceuticals ULC; listing date 2010-03-02
Daily cost (source): $0.4120
Health Canada: Marketed since 2018-10-24 · brand CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 3.125 MG · company Sivem pharmaceuticals ulc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordCarvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.
Ministry pays: $0.2060 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02248752)
Source record
DIN 02248752: Carvedilol
Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y
Item: 240400140; group id 278; item number 0576; lccId 00050; manufacturer id SIV
Source form: Tab; strength: 3.125mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.2060; ministry $0.2060
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02248752
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=73120
Interchangeable products
Apo-Carvedilol · DIN 02247933 · $0.2060
Auro-Carvedilol · DIN 02418495 · $0.2060
Carvedilol · DIN 02364913 · $0.2060
Coreg · DIN 02229650 · not recorded
Jamp-Carvedilol · DIN 02368897 · $0.2060
PMS-Carvedilol · DIN 02245914 · $0.2060
Ran-Carvedilol · DIN 02268027 · $0.2060
Ratio-Carvedilol · DIN 02252309 · $0.2060
Shortage status: resolved shortage (ended May 20, 2020); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02248752
Shortage record checked October 6, 2026
Carvedilol · DIN 02364913 · 3.125 mg · tablet
Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit:
For patients with:
Reason for Use code 183
a) NYHA Class II or III Congestive Heart Failure (CHF); and
b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and
c) An ejection fraction less than or equal to 35%; and
d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Carvedilol · DIN 02364913
Manufacturer: Sanis Health Inc.; listing date 2011-10-25
Daily cost (source): $0.4120
Health Canada: Marketed since 2013-10-12 · brand CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 3.125 MG · company Sanis health inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordCarvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.
Ministry pays: $0.2060 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02364913)
Source record
DIN 02364913: Carvedilol
Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y
Item: 240400140; group id 278; item number 0576; lccId 00050; manufacturer id SAI
Source form: Tab; strength: 3.125mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.2060; ministry $0.2060
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02364913
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=84979
Interchangeable products
Apo-Carvedilol · DIN 02247933 · $0.2060
Auro-Carvedilol · DIN 02418495 · $0.2060
Carvedilol · DIN 02248752 · $0.2060
Coreg · DIN 02229650 · not recorded
Jamp-Carvedilol · DIN 02368897 · $0.2060
PMS-Carvedilol · DIN 02245914 · $0.2060
Ran-Carvedilol · DIN 02268027 · $0.2060
Ratio-Carvedilol · DIN 02252309 · $0.2060
Shortage status: resolved shortage (ended November 25, 2024); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02364913
Shortage record checked October 6, 2026
Jamp-Carvedilol · DIN 02368897 · 3.125 mg · tablet
Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit:
For patients with:
Reason for Use code 183
a) NYHA Class II or III Congestive Heart Failure (CHF); and
b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and
c) An ejection fraction less than or equal to 35%; and
d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Jamp-Carvedilol · DIN 02368897
Manufacturer: Jamp Pharma Corporation; listing date 2012-08-27
Daily cost (source): $0.4120
Health Canada: Marketed since 2022-01-12 · brand JAMP-CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 3.125 MG · company Jamp pharma corporation · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordJamp-Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.
Ministry pays: $0.2060 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02368897)
Source record
DIN 02368897: Jamp-Carvedilol
Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y
Item: 240400140; group id 278; item number 0576; lccId 00050; manufacturer id JPC
Source form: Tab; strength: 3.125mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.2060; ministry $0.2060
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02368897
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=85386
Interchangeable products
Apo-Carvedilol · DIN 02247933 · $0.2060
Auro-Carvedilol · DIN 02418495 · $0.2060
Carvedilol · DIN 02248752 · $0.2060
Carvedilol · DIN 02364913 · $0.2060
Coreg · DIN 02229650 · not recorded
PMS-Carvedilol · DIN 02245914 · $0.2060
Ran-Carvedilol · DIN 02268027 · $0.2060
Ratio-Carvedilol · DIN 02252309 · $0.2060
Shortage status: resolved shortage (ended August 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02368897
Shortage record checked October 6, 2026
PMS-Carvedilol · DIN 02245914 · 3.125 mg · tablet
Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit:
For patients with:
Reason for Use code 183
a) NYHA Class II or III Congestive Heart Failure (CHF); and
b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and
c) An ejection fraction less than or equal to 35%; and
d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
PMS-Carvedilol · DIN 02245914
Manufacturer: Pharmascience Inc.; listing date 2004-04-06
Daily cost (source): $0.4120
Health Canada: Marketed since 2003-08-04 · brand PMS-CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 3.125 MG · company Pharmascience inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordPMS-Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.
Ministry pays: $0.2060 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02245914)
Source record
DIN 02245914: PMS-Carvedilol
Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y
Item: 240400140; group id 278; item number 0576; lccId 00050; manufacturer id PMS
Source form: Tab; strength: 3.125mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.2060; ministry $0.2060
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02245914
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=70034
Interchangeable products
Apo-Carvedilol · DIN 02247933 · $0.2060
Auro-Carvedilol · DIN 02418495 · $0.2060
Carvedilol · DIN 02248752 · $0.2060
Carvedilol · DIN 02364913 · $0.2060
Coreg · DIN 02229650 · not recorded
Jamp-Carvedilol · DIN 02368897 · $0.2060
Ran-Carvedilol · DIN 02268027 · $0.2060
Ratio-Carvedilol · DIN 02252309 · $0.2060
Shortage status: resolved shortage (ended June 26, 2018); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02245914
Shortage record checked October 6, 2026
Ratio-Carvedilol · DIN 02252309 · 3.125 mg · tablet
Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit:
For patients with:
Reason for Use code 183
a) NYHA Class II or III Congestive Heart Failure (CHF); and
b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and
c) An ejection fraction less than or equal to 35%; and
d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Ratio-Carvedilol · DIN 02252309
Manufacturer: Ratiopharm Inc.; listing date 2004-07-20
Daily cost (source): $0.4120
Health Canada: Marketed since 2018-01-09 · brand TEVA-CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 3.125 MG · company Teva canada limited · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordRatio-Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.
Ministry pays: $0.2060 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02252309)
Source record
DIN 02252309: Ratio-Carvedilol
Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y
Item: 240400140; group id 278; item number 0576; lccId 00050; manufacturer id RPH
Source form: Tab; strength: 3.125mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.2060; ministry $0.2060
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02252309
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=73718
Interchangeable products
Apo-Carvedilol · DIN 02247933 · $0.2060
Auro-Carvedilol · DIN 02418495 · $0.2060
Carvedilol · DIN 02248752 · $0.2060
Carvedilol · DIN 02364913 · $0.2060
Coreg · DIN 02229650 · not recorded
Jamp-Carvedilol · DIN 02368897 · $0.2060
PMS-Carvedilol · DIN 02245914 · $0.2060
Ran-Carvedilol · DIN 02268027 · $0.2060
Shortage status: resolved shortage (ended May 5, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02252309
Shortage record checked October 6, 2026
Auro-Carvedilol · DIN 02418509 · 6.25 mg · tablet
Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit:
For patients with:
Reason for Use code 183
a) NYHA Class II or III Congestive Heart Failure (CHF); and
b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and
c) An ejection fraction less than or equal to 35%; and
d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Auro-Carvedilol · DIN 02418509
Manufacturer: Auro Pharma Inc.; listing date 2014-04-30
Daily cost (source): $0.4120
Health Canada: Marketed since 2014-02-06 · brand AURO-CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 6.25 MG · company Auro pharma inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordAuro-Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.
Ministry pays: $0.2060 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02418509)
Source record
DIN 02418509: Auro-Carvedilol
Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y
Item: 240400141; group id 278; item number 0577; lccId 00050; manufacturer id AUR
Source form: Tab; strength: 6.25mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.2060; ministry $0.2060
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02418509
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=90307
Interchangeable products
Apo-Carvedilol · DIN 02247934 · $0.2060
Carvedilol · DIN 02248753 · $0.2060
Carvedilol · DIN 02364921 · $0.2060
Coreg · DIN 02229651 · not recorded
Jamp-Carvedilol · DIN 02368900 · $0.2060
PMS-Carvedilol · DIN 02245915 · $0.2060
Ran-Carvedilol · DIN 02268035 · $0.2060
Ratio-Carvedilol · DIN 02252317 · $0.2060
Shortage status: resolved shortage (ended March 29, 2022); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02418509
Shortage record checked October 6, 2026
Carvedilol · DIN 02248753 · 6.25 mg · tablet
Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit:
For patients with:
Reason for Use code 183
a) NYHA Class II or III Congestive Heart Failure (CHF); and
b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and
c) An ejection fraction less than or equal to 35%; and
d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Carvedilol · DIN 02248753
Manufacturer: Sivem Pharmaceuticals ULC; listing date 2010-03-02
Daily cost (source): $0.4120
Health Canada: Marketed since 2018-07-06 · brand CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 6.25 MG · company Sivem pharmaceuticals ulc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordCarvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.
Ministry pays: $0.2060 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02248753)
Source record
DIN 02248753: Carvedilol
Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y
Item: 240400141; group id 278; item number 0577; lccId 00050; manufacturer id SIV
Source form: Tab; strength: 6.25mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.2060; ministry $0.2060
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02248753
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=73121
Interchangeable products
Apo-Carvedilol · DIN 02247934 · $0.2060
Auro-Carvedilol · DIN 02418509 · $0.2060
Carvedilol · DIN 02364921 · $0.2060
Coreg · DIN 02229651 · not recorded
Jamp-Carvedilol · DIN 02368900 · $0.2060
PMS-Carvedilol · DIN 02245915 · $0.2060
Ran-Carvedilol · DIN 02268035 · $0.2060
Ratio-Carvedilol · DIN 02252317 · $0.2060
Shortage status: resolved shortage (ended September 3, 2018); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02248753
Shortage record checked October 6, 2026
Carvedilol · DIN 02364921 · 6.25 mg · tablet
Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit:
For patients with:
Reason for Use code 183
a) NYHA Class II or III Congestive Heart Failure (CHF); and
b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and
c) An ejection fraction less than or equal to 35%; and
d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Carvedilol · DIN 02364921
Manufacturer: Sanis Health Inc.; listing date 2011-10-25
Daily cost (source): $0.4120
Health Canada: Marketed since 2013-10-12 · brand CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 6.25 MG · company Sanis health inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordCarvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.
Ministry pays: $0.2060 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02364921)
Source record
DIN 02364921: Carvedilol
Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y
Item: 240400141; group id 278; item number 0577; lccId 00050; manufacturer id SAI
Source form: Tab; strength: 6.25mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.2060; ministry $0.2060
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02364921
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=84980
Interchangeable products
Apo-Carvedilol · DIN 02247934 · $0.2060
Auro-Carvedilol · DIN 02418509 · $0.2060
Carvedilol · DIN 02248753 · $0.2060
Coreg · DIN 02229651 · not recorded
Jamp-Carvedilol · DIN 02368900 · $0.2060
PMS-Carvedilol · DIN 02245915 · $0.2060
Ran-Carvedilol · DIN 02268035 · $0.2060
Ratio-Carvedilol · DIN 02252317 · $0.2060
Shortage status: resolved shortage (ended August 18, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02364921
Shortage record checked October 6, 2026
Jamp-Carvedilol · DIN 02368900 · 6.25 mg · tablet
Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit:
For patients with:
Reason for Use code 183
a) NYHA Class II or III Congestive Heart Failure (CHF); and
b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and
c) An ejection fraction less than or equal to 35%; and
d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Jamp-Carvedilol · DIN 02368900
Manufacturer: Jamp Pharma Corporation; listing date 2012-08-27
Daily cost (source): $0.4120
Health Canada: Marketed since 2022-01-12 · brand JAMP-CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 6.25 MG · company Jamp pharma corporation · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordJamp-Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.
Ministry pays: $0.2060 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02368900)
Source record
DIN 02368900: Jamp-Carvedilol
Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y
Item: 240400141; group id 278; item number 0577; lccId 00050; manufacturer id JPC
Source form: Tab; strength: 6.25mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.2060; ministry $0.2060
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02368900
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=85387
Interchangeable products
Apo-Carvedilol · DIN 02247934 · $0.2060
Auro-Carvedilol · DIN 02418509 · $0.2060
Carvedilol · DIN 02248753 · $0.2060
Carvedilol · DIN 02364921 · $0.2060
Coreg · DIN 02229651 · not recorded
PMS-Carvedilol · DIN 02245915 · $0.2060
Ran-Carvedilol · DIN 02268035 · $0.2060
Ratio-Carvedilol · DIN 02252317 · $0.2060
Shortage status: resolved shortage (ended March 27, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02368900
Shortage record checked October 6, 2026
PMS-Carvedilol · DIN 02245915 · 6.25 mg · tablet
Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit:
For patients with:
Reason for Use code 183
a) NYHA Class II or III Congestive Heart Failure (CHF); and
b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and
c) An ejection fraction less than or equal to 35%; and
d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
PMS-Carvedilol · DIN 02245915
Manufacturer: Pharmascience Inc.; listing date 2004-04-06
Daily cost (source): $0.4120
Health Canada: Marketed since 2003-08-04 · brand PMS-CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 6.25 MG · company Pharmascience inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordPMS-Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.
Ministry pays: $0.2060 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02245915)
Source record
DIN 02245915: PMS-Carvedilol
Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y
Item: 240400141; group id 278; item number 0577; lccId 00050; manufacturer id PMS
Source form: Tab; strength: 6.25mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.2060; ministry $0.2060
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02245915
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=70035
Interchangeable products
Apo-Carvedilol · DIN 02247934 · $0.2060
Auro-Carvedilol · DIN 02418509 · $0.2060
Carvedilol · DIN 02248753 · $0.2060
Carvedilol · DIN 02364921 · $0.2060
Coreg · DIN 02229651 · not recorded
Jamp-Carvedilol · DIN 02368900 · $0.2060
Ran-Carvedilol · DIN 02268035 · $0.2060
Ratio-Carvedilol · DIN 02252317 · $0.2060
Shortage status: resolved shortage (ended June 26, 2018); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02245915
Shortage record checked October 6, 2026
Ratio-Carvedilol · DIN 02252317 · 6.25 mg · tablet
Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit:
For patients with:
Reason for Use code 183
a) NYHA Class II or III Congestive Heart Failure (CHF); and
b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and
c) An ejection fraction less than or equal to 35%; and
d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Ratio-Carvedilol · DIN 02252317
Manufacturer: Ratiopharm Inc.; listing date 2004-07-20
Daily cost (source): $0.4120
Health Canada: Marketed since 2018-01-09 · brand TEVA-CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 6.25 MG · company Teva canada limited · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordRatio-Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.
Ministry pays: $0.2060 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02252317)
Source record
DIN 02252317: Ratio-Carvedilol
Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y
Item: 240400141; group id 278; item number 0577; lccId 00050; manufacturer id RPH
Source form: Tab; strength: 6.25mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.2060; ministry $0.2060
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02252317
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=73719
Interchangeable products
Apo-Carvedilol · DIN 02247934 · $0.2060
Auro-Carvedilol · DIN 02418509 · $0.2060
Carvedilol · DIN 02248753 · $0.2060
Carvedilol · DIN 02364921 · $0.2060
Coreg · DIN 02229651 · not recorded
Jamp-Carvedilol · DIN 02368900 · $0.2060
PMS-Carvedilol · DIN 02245915 · $0.2060
Ran-Carvedilol · DIN 02268035 · $0.2060
Shortage status: resolved shortage (ended May 5, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02252317
Shortage record checked October 6, 2026
Auro-Carvedilol · DIN 02418517 · 12.5 mg · tablet
Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit:
For patients with:
Reason for Use code 183
a) NYHA Class II or III Congestive Heart Failure (CHF); and
b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and
c) An ejection fraction less than or equal to 35%; and
d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Auro-Carvedilol · DIN 02418517
Manufacturer: Auro Pharma Inc.; listing date 2014-04-30
Daily cost (source): $0.4120
Health Canada: Marketed since 2014-02-06 · brand AURO-CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 12.5 MG · company Auro pharma inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordAuro-Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.
Ministry pays: $0.2060 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02418517)
Source record
DIN 02418517: Auro-Carvedilol
Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y
Item: 240400142; group id 278; item number 0578; lccId 00050; manufacturer id AUR
Source form: Tab; strength: 12.5mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.2060; ministry $0.2060
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02418517
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=90308
Interchangeable products
Apo-Carvedilol · DIN 02247935 · $0.2060
Carvedilol · DIN 02248754 · $0.2060
Carvedilol · DIN 02364948 · $0.2060
Coreg · DIN 02229652 · not recorded
Jamp-Carvedilol · DIN 02368919 · $0.2060
PMS-Carvedilol · DIN 02245916 · $0.2060
Ran-Carvedilol · DIN 02268043 · $0.2060
Ratio-Carvedilol · DIN 02252325 · $0.2060
Shortage status: resolved shortage (ended October 28, 2024); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02418517
Shortage record checked October 6, 2026
Carvedilol · DIN 02248754 · 12.5 mg · tablet
Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit:
For patients with:
Reason for Use code 183
a) NYHA Class II or III Congestive Heart Failure (CHF); and
b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and
c) An ejection fraction less than or equal to 35%; and
d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Carvedilol · DIN 02248754
Manufacturer: Sivem Pharmaceuticals ULC; listing date 2010-03-02
Daily cost (source): $0.4120
Health Canada: Marketed since 2018-07-06 · brand CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 12.5 MG · company Sivem pharmaceuticals ulc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordCarvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.
Ministry pays: $0.2060 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02248754)
Source record
DIN 02248754: Carvedilol
Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y
Item: 240400142; group id 278; item number 0578; lccId 00050; manufacturer id SIV
Source form: Tab; strength: 12.5mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.2060; ministry $0.2060
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02248754
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=73122
Interchangeable products
Apo-Carvedilol · DIN 02247935 · $0.2060
Auro-Carvedilol · DIN 02418517 · $0.2060
Carvedilol · DIN 02364948 · $0.2060
Coreg · DIN 02229652 · not recorded
Jamp-Carvedilol · DIN 02368919 · $0.2060
PMS-Carvedilol · DIN 02245916 · $0.2060
Ran-Carvedilol · DIN 02268043 · $0.2060
Ratio-Carvedilol · DIN 02252325 · $0.2060
Shortage status: resolved shortage (ended August 12, 2019); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02248754
Shortage record checked October 6, 2026
Carvedilol · DIN 02364948 · 12.5 mg · tablet
Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit:
For patients with:
Reason for Use code 183
a) NYHA Class II or III Congestive Heart Failure (CHF); and
b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and
c) An ejection fraction less than or equal to 35%; and
d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Carvedilol · DIN 02364948
Manufacturer: Sanis Health Inc.; listing date 2011-10-25
Daily cost (source): $0.4120
Health Canada: Marketed since 2013-10-12 · brand CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 12.5 MG · company Sanis health inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordCarvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.
Ministry pays: $0.2060 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02364948)
Source record
DIN 02364948: Carvedilol
Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y
Item: 240400142; group id 278; item number 0578; lccId 00050; manufacturer id SAI
Source form: Tab; strength: 12.5mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.2060; ministry $0.2060
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02364948
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=84981
Interchangeable products
Apo-Carvedilol · DIN 02247935 · $0.2060
Auro-Carvedilol · DIN 02418517 · $0.2060
Carvedilol · DIN 02248754 · $0.2060
Coreg · DIN 02229652 · not recorded
Jamp-Carvedilol · DIN 02368919 · $0.2060
PMS-Carvedilol · DIN 02245916 · $0.2060
Ran-Carvedilol · DIN 02268043 · $0.2060
Ratio-Carvedilol · DIN 02252325 · $0.2060
Shortage status: resolved shortage (ended April 22, 2024); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02364948
Shortage record checked October 6, 2026
Jamp-Carvedilol · DIN 02368919 · 12.5 mg · tablet
Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit:
For patients with:
Reason for Use code 183
a) NYHA Class II or III Congestive Heart Failure (CHF); and
b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and
c) An ejection fraction less than or equal to 35%; and
d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Jamp-Carvedilol · DIN 02368919
Manufacturer: Jamp Pharma Corporation; listing date 2012-08-27
Daily cost (source): $0.4120
Health Canada: Marketed since 2022-01-12 · brand JAMP-CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 12.5 MG · company Jamp pharma corporation · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordJamp-Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.
Ministry pays: $0.2060 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02368919)
Source record
DIN 02368919: Jamp-Carvedilol
Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y
Item: 240400142; group id 278; item number 0578; lccId 00050; manufacturer id JPC
Source form: Tab; strength: 12.5mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.2060; ministry $0.2060
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02368919
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=85388
Interchangeable products
Apo-Carvedilol · DIN 02247935 · $0.2060
Auro-Carvedilol · DIN 02418517 · $0.2060
Carvedilol · DIN 02248754 · $0.2060
Carvedilol · DIN 02364948 · $0.2060
Coreg · DIN 02229652 · not recorded
PMS-Carvedilol · DIN 02245916 · $0.2060
Ran-Carvedilol · DIN 02268043 · $0.2060
Ratio-Carvedilol · DIN 02252325 · $0.2060
Shortage status: resolved shortage (ended July 13, 2022); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02368919
Shortage record checked October 6, 2026
PMS-Carvedilol · DIN 02245916 · 12.5 mg · tablet
Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit:
For patients with:
Reason for Use code 183
a) NYHA Class II or III Congestive Heart Failure (CHF); and
b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and
c) An ejection fraction less than or equal to 35%; and
d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
PMS-Carvedilol · DIN 02245916
Manufacturer: Pharmascience Inc.; listing date 2004-04-06
Daily cost (source): $0.4120
Health Canada: Marketed since 2003-08-04 · brand PMS-CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 12.5 MG · company Pharmascience inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordPMS-Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.
Ministry pays: $0.2060 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02245916)
Source record
DIN 02245916: PMS-Carvedilol
Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y
Item: 240400142; group id 278; item number 0578; lccId 00050; manufacturer id PMS
Source form: Tab; strength: 12.5mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.2060; ministry $0.2060
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02245916
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=70036
Interchangeable products
Apo-Carvedilol · DIN 02247935 · $0.2060
Auro-Carvedilol · DIN 02418517 · $0.2060
Carvedilol · DIN 02248754 · $0.2060
Carvedilol · DIN 02364948 · $0.2060
Coreg · DIN 02229652 · not recorded
Jamp-Carvedilol · DIN 02368919 · $0.2060
Ran-Carvedilol · DIN 02268043 · $0.2060
Ratio-Carvedilol · DIN 02252325 · $0.2060
Shortage status: resolved shortage (ended July 12, 2018); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02245916
Shortage record checked October 6, 2026
Ratio-Carvedilol · DIN 02252325 · 12.5 mg · tablet
Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit:
For patients with:
Reason for Use code 183
a) NYHA Class II or III Congestive Heart Failure (CHF); and
b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and
c) An ejection fraction less than or equal to 35%; and
d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Ratio-Carvedilol · DIN 02252325
Manufacturer: Ratiopharm Inc.; listing date 2004-07-20
Daily cost (source): $0.4120
Health Canada: Marketed since 2018-01-09 · brand TEVA-CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 12.5 MG · company Teva canada limited · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordRatio-Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.
Ministry pays: $0.2060 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02252325)
Source record
DIN 02252325: Ratio-Carvedilol
Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y
Item: 240400142; group id 278; item number 0578; lccId 00050; manufacturer id RPH
Source form: Tab; strength: 12.5mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.2060; ministry $0.2060
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02252325
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=73720
Interchangeable products
Apo-Carvedilol · DIN 02247935 · $0.2060
Auro-Carvedilol · DIN 02418517 · $0.2060
Carvedilol · DIN 02248754 · $0.2060
Carvedilol · DIN 02364948 · $0.2060
Coreg · DIN 02229652 · not recorded
Jamp-Carvedilol · DIN 02368919 · $0.2060
PMS-Carvedilol · DIN 02245916 · $0.2060
Ran-Carvedilol · DIN 02268043 · $0.2060
Shortage status: resolved shortage (ended May 5, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02252325
Shortage record checked October 6, 2026
Auro-Carvedilol · DIN 02418525 · 25 mg · tablet
Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit:
For patients with:
Reason for Use code 183
a) NYHA Class II or III Congestive Heart Failure (CHF); and
b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and
c) An ejection fraction less than or equal to 35%; and
d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Auro-Carvedilol · DIN 02418525
Manufacturer: Auro Pharma Inc.; listing date 2014-04-30
Daily cost (source): $0.4120
Health Canada: Marketed since 2014-02-06 · brand AURO-CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 25 MG · company Auro pharma inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordAuro-Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.
Ministry pays: $0.2060 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02418525)
Source record
DIN 02418525: Auro-Carvedilol
Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y
Item: 240400143; group id 278; item number 0579; lccId 00050; manufacturer id AUR
Source form: Tab; strength: 25mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.2060; ministry $0.2060
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02418525
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=90309
Interchangeable products
Apo-Carvedilol · DIN 02247936 · $0.2060
Carvedilol · DIN 02248755 · $0.2060
Carvedilol · DIN 02364956 · $0.2060
Coreg · DIN 02229653 · not recorded
Jamp-Carvedilol · DIN 02368927 · $0.2060
PMS-Carvedilol · DIN 02245917 · $0.2060
Ran-Carvedilol · DIN 02268051 · $0.2060
Ratio-Carvedilol · DIN 02252333 · $0.2060
Shortage status: resolved shortage (ended October 28, 2024); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02418525
Shortage record checked October 6, 2026
Carvedilol · DIN 02248755 · 25 mg · tablet
Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit:
For patients with:
Reason for Use code 183
a) NYHA Class II or III Congestive Heart Failure (CHF); and
b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and
c) An ejection fraction less than or equal to 35%; and
d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Carvedilol · DIN 02248755
Manufacturer: Sivem Pharmaceuticals ULC; listing date 2010-03-02
Daily cost (source): $0.4120
Health Canada: Marketed since 2018-07-06 · brand CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 25 MG · company Sivem pharmaceuticals ulc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordCarvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.
Ministry pays: $0.2060 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02248755)
Source record
DIN 02248755: Carvedilol
Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y
Item: 240400143; group id 278; item number 0579; lccId 00050; manufacturer id SIV
Source form: Tab; strength: 25mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.2060; ministry $0.2060
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02248755
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=73123
Interchangeable products
Apo-Carvedilol · DIN 02247936 · $0.2060
Auro-Carvedilol · DIN 02418525 · $0.2060
Carvedilol · DIN 02364956 · $0.2060
Coreg · DIN 02229653 · not recorded
Jamp-Carvedilol · DIN 02368927 · $0.2060
PMS-Carvedilol · DIN 02245917 · $0.2060
Ran-Carvedilol · DIN 02268051 · $0.2060
Ratio-Carvedilol · DIN 02252333 · $0.2060
Shortage status: resolved shortage (ended September 3, 2018); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02248755
Shortage record checked October 6, 2026
Carvedilol · DIN 02364956 · 25 mg · tablet
Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit:
For patients with:
Reason for Use code 183
a) NYHA Class II or III Congestive Heart Failure (CHF); and
b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and
c) An ejection fraction less than or equal to 35%; and
d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Carvedilol · DIN 02364956
Manufacturer: Sanis Health Inc.; listing date 2011-10-25
Daily cost (source): $0.4120
Health Canada: Marketed since 2013-10-12 · brand CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 25 MG · company Sanis health inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordCarvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.
Ministry pays: $0.2060 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02364956)
Source record
DIN 02364956: Carvedilol
Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y
Item: 240400143; group id 278; item number 0579; lccId 00050; manufacturer id SAI
Source form: Tab; strength: 25mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.2060; ministry $0.2060
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02364956
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=84982
Interchangeable products
Apo-Carvedilol · DIN 02247936 · $0.2060
Auro-Carvedilol · DIN 02418525 · $0.2060
Carvedilol · DIN 02248755 · $0.2060
Coreg · DIN 02229653 · not recorded
Jamp-Carvedilol · DIN 02368927 · $0.2060
PMS-Carvedilol · DIN 02245917 · $0.2060
Ran-Carvedilol · DIN 02268051 · $0.2060
Ratio-Carvedilol · DIN 02252333 · $0.2060
Shortage status: resolved shortage (ended October 1, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02364956
Shortage record checked October 6, 2026
Jamp-Carvedilol · DIN 02368927 · 25 mg · tablet
Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit:
For patients with:
Reason for Use code 183
a) NYHA Class II or III Congestive Heart Failure (CHF); and
b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and
c) An ejection fraction less than or equal to 35%; and
d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Jamp-Carvedilol · DIN 02368927
Manufacturer: Jamp Pharma Corporation; listing date 2012-08-27
Daily cost (source): $0.4120
Health Canada: Marketed since 2022-01-12 · brand JAMP-CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 25 MG · company Jamp pharma corporation · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordJamp-Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.
Ministry pays: $0.2060 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02368927)
Source record
DIN 02368927: Jamp-Carvedilol
Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y
Item: 240400143; group id 278; item number 0579; lccId 00050; manufacturer id JPC
Source form: Tab; strength: 25mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.2060; ministry $0.2060
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02368927
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=85389
Interchangeable products
Apo-Carvedilol · DIN 02247936 · $0.2060
Auro-Carvedilol · DIN 02418525 · $0.2060
Carvedilol · DIN 02248755 · $0.2060
Carvedilol · DIN 02364956 · $0.2060
Coreg · DIN 02229653 · not recorded
PMS-Carvedilol · DIN 02245917 · $0.2060
Ran-Carvedilol · DIN 02268051 · $0.2060
Ratio-Carvedilol · DIN 02252333 · $0.2060
Shortage status: resolved shortage (ended July 13, 2022); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02368927
Shortage record checked October 6, 2026
PMS-Carvedilol · DIN 02245917 · 25 mg · tablet
Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit:
For patients with:
Reason for Use code 183
a) NYHA Class II or III Congestive Heart Failure (CHF); and
b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and
c) An ejection fraction less than or equal to 35%; and
d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
PMS-Carvedilol · DIN 02245917
Manufacturer: Pharmascience Inc.; listing date 2004-04-06
Daily cost (source): $0.4120
Health Canada: Marketed since 2003-08-04 · brand PMS-CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 25 MG · company Pharmascience inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordPMS-Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.
Ministry pays: $0.2060 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02245917)
Source record
DIN 02245917: PMS-Carvedilol
Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y
Item: 240400143; group id 278; item number 0579; lccId 00050; manufacturer id PMS
Source form: Tab; strength: 25mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.2060; ministry $0.2060
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02245917
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=70037
Interchangeable products
Apo-Carvedilol · DIN 02247936 · $0.2060
Auro-Carvedilol · DIN 02418525 · $0.2060
Carvedilol · DIN 02248755 · $0.2060
Carvedilol · DIN 02364956 · $0.2060
Coreg · DIN 02229653 · not recorded
Jamp-Carvedilol · DIN 02368927 · $0.2060
Ran-Carvedilol · DIN 02268051 · $0.2060
Ratio-Carvedilol · DIN 02252333 · $0.2060
Shortage status: resolved shortage (ended September 16, 2026); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02245917
Shortage record checked October 6, 2026
Ratio-Carvedilol · DIN 02252333 · 25 mg · tablet
Limited Use, Reason for Use code 183 requiredMarketed · checked October 5, 2026
Write on scriptReason for Use code 183 (criteria below)
Ontario Limited Use criteria, code 183
Coverage limit:
For patients with:
Reason for Use code 183
a) NYHA Class II or III Congestive Heart Failure (CHF); and
b) Currently being treated with an angiotensin converting enzyme (ACE) inhibitor, diuretics with or without digoxin, or previously treated, and failed these agents; and
c) An ejection fraction less than or equal to 35%; and
d) At least one episode of symptomatic CHF within a 12 month period while receiving optimal management.
Coverage limit:
LU Authorization Period: Indefinite
1 brand, same coverage
Ratio-Carvedilol · DIN 02252333
Manufacturer: Ratiopharm Inc.; listing date 2004-07-20
Daily cost (source): $0.4120
Health Canada: Marketed since 2018-01-09 · brand TEVA-CARVEDILOL · ATC C07AG02 CARVEDILOL · form Tablet · route Oral · ingredients CARVEDILOL 25 MG · company Teva canada limited · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product recordRatio-Carvedilol: Formulary list price $0.21 per unit (the source does not state the unit; exact figure $0.2060). What the ministry pays, not the patient.
Ministry pays: $0.2060 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02252333)
Source record
DIN 02252333: Ratio-Carvedilol
Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y
Item: 240400143; group id 278; item number 0579; lccId 00050; manufacturer id RPH
Source form: Tab; strength: 25mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $0.2060; ministry $0.2060
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02252333
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=73721
Interchangeable products
Apo-Carvedilol · DIN 02247936 · $0.2060
Auro-Carvedilol · DIN 02418525 · $0.2060
Carvedilol · DIN 02248755 · $0.2060
Carvedilol · DIN 02364956 · $0.2060
Coreg · DIN 02229653 · not recorded
Jamp-Carvedilol · DIN 02368927 · $0.2060
PMS-Carvedilol · DIN 02245917 · $0.2060
Ran-Carvedilol · DIN 02268051 · $0.2060
Shortage status: resolved shortage (ended October 1, 2025); reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02252333
Shortage record checked October 6, 2026
Other products in the same Health Canada class (C07A): coverage varies; not interchangeable
- Acebutolol (Sectral): general benefit, not a benefit
- Atenolol (Apo-Atenol): general benefit
- Bisoprolol (Sandoz Bisoprolol Tablets): general benefit, not a benefit
- Metoprolol (Lopresor SR): general benefit, not a benefit
- Nadolol (Corgard): general benefit, not a benefit
- Propranolol (Inderal-LA): general benefit, not a benefit
3 more in the class list below
Other drugs in the same formulary class (24:04 Cardiac Drugs) and how they are covered
Matched class: 24:04 Cardiac Drugs
Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment.
Covered without a code on the Ontario formulary: ATENOLOL, DIGOXIN, PROPAFENONE HCL
Some products covered without a code (check the product listing): ACEBUTOLOL HCL, AMIODARONE HCL, AMLODIPINE, BISOPROLOL FUMARATE, DILTIAZEM HCL, DISOPYRAMIDE, FLECAINIDE ACETATE, METOPROLOL TARTRATE, MEXILETINE HCL, NADOLOL, NIFEDIPINE, PROPRANOLOL, SOTALOL HCL, TIMOLOL MALEATE, VERAPAMIL HCL
24:00 CARDIOVASCULAR DRUGS
· 2 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 500mg · ER Tab
Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 24:00
24:04 Cardiac Drugs
· 9 products · Listed, not a benefit (3), General benefit (6) · strengths: 100mg, 200mg, 400mg · Tab
· 26 products · General benefit · strengths: 50mg, 100mg · Tab
· 20 products · General benefit (18), Listed, not a benefit (2) · strengths: 1.25mg, 2.5mg, 5mg, 10mg · Tab
· 28 products · Listed, not a benefit (6), General benefit (22) · strengths: 100mg, 200mg, 50mg · LA Tab, Tab
· 8 products · Listed, not a benefit (3), General benefit (5) · strengths: 40mg, 80mg, 160mg · Tab
· 19 products · Off-Formulary Interchangeable, not an ODB benefit (8), General benefit (7), Listed, not a benefit (4) · strengths: 60mg, 80mg, 120mg, 160mg, 10mg, 20mg, 40mg · LA Cap, Tab
· 10 products · Listed, not a benefit (2), General benefit (8) · strengths: 80mg, 160mg · Tab
· 6 products · Listed, not a benefit (3), General benefit (3) · strengths: 5mg, 10mg, 20mg · Tab
· 8 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 2.5mg, 5mg, 10mg, 20mg · Tab
· 9 products · Listed, not a benefit (1), General benefit (8) · strengths: 200mg · Tab
· 59 products ·
Limited Use, codes 645, 706 (1), Off-Formulary Interchangeable, not an ODB benefit (12), General benefit (46) · strengths: 1mg/mL, 2.5mg, 5mg, 10mg · Oral Sol, Tab
Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 24:04
and 9 more
Full class listing
Related classes: 24:06 Antilipemic Drugs, 24:08 Hypotensive Drugs (For Diuretics See 40:28), 24:12 Vasodilating Drugs, 24:32 Renin-Angiotensin Aldosterone Inhibitors
Same formulary class, not same indication: class membership alone does not establish equivalent uses.